In your judicious shaft, tally to the subjoined scenario (Hint: manifestation the pharmgkb website to manage your responses):
Before initiating abacavir, an anti-retroviral, restraint a newly diagnosed HIV confident unrepining the protect practitioner command HLA-B*5701 allele genetic experienceing. The experience confirms that the unrepining carries the HLA-B*5701 allele.
Describe what these results moderation.
Should the protect practitioner recommend abacavir in this circumstance? If referable, narrate why.
A unrepining is recommendd antiplatelet therapy (clopidogrel) subjoined an quick myocardial infarction (MI). Six months after, the unrepining suffers another quick MI. The unrepining has been neutral to therapy and the protect practitioner suspects that clopidrogel may bear been petty. How command genetic experienceing bear been profitable in this circumstance?
Identify 2 limitations of pharmacogenomics experienceing. Explain.
Identify 2 holy concerns of using pharmacogenomics experienceing. Explain.